<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>23(15)</volume><submitter>Liang Y</submitter><pubmed_abstract>Ribonuclease S (RNase S) is an enzyme that exhibits anticancer activity by degrading RNAs within cancer cells; however, the cellular uptake efficiency is low due to its small molecular size. Here we generated RNase S-decorated artificial viral capsids with a size of 70-170 nm by self-assembly of the β-annulus-S-peptide followed by reconstitution with S-protein at neutral pH. The RNase S-decorated artificial viral capsids are efficiently taken up by HepG2 cells and exhibit higher RNA degradation activity in cells compared with RNase S alone. Cell viability assays revealed that RNase S-decorated capsids have high anticancer activity comparable to that of standard anticancer drugs.</pubmed_abstract><journal>Chembiochem : a European journal of chemical biology</journal><pagination>e202200220</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9400862</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Anticancer Activity of Reconstituted Ribonuclease S-Decorated Artificial Viral Capsid.</pubmed_title><pmcid>PMC9400862</pmcid><pubmed_authors>Inaba H</pubmed_authors><pubmed_authors>Furukawa H</pubmed_authors><pubmed_authors>Liang Y</pubmed_authors><pubmed_authors>Sakamoto K</pubmed_authors><pubmed_authors>Matsuura K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Anticancer Activity of Reconstituted Ribonuclease S-Decorated Artificial Viral Capsid.</name><description>Ribonuclease S (RNase S) is an enzyme that exhibits anticancer activity by degrading RNAs within cancer cells; however, the cellular uptake efficiency is low due to its small molecular size. Here we generated RNase S-decorated artificial viral capsids with a size of 70-170 nm by self-assembly of the β-annulus-S-peptide followed by reconstitution with S-protein at neutral pH. The RNase S-decorated artificial viral capsids are efficiently taken up by HepG2 cells and exhibit higher RNA degradation activity in cells compared with RNase S alone. Cell viability assays revealed that RNase S-decorated capsids have high anticancer activity comparable to that of standard anticancer drugs.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-04T03:26:13.82Z</modification><creation>2025-04-04T03:26:13.82Z</creation></dates><accession>S-EPMC9400862</accession><cross_references><pubmed>35676201</pubmed><doi>10.1002/cbic.202200220</doi></cross_references></HashMap>